Clinical Trial Update: Assessing Ocular Surface Changes After Changing Glaucoma Medications

View source ↗

Summary

A completed clinical trial from the University of Colorado, Denver assessed ocular surface changes after switching glaucoma medications. The study focused on la…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Surface Disease

Drugs mentioned

• Xalatan (latanoprost)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Glaucoma, Monotherapy With Xalatan From 1 to 18 Months | Status: COMPLETED